Skip to main content
SpringerLink
Log in
Book cover

Nicotine Psychopharmacology pp 335–367Cite as

Effects of Nicotine in Experimental Animals and Humans: An Update on Addictive Properties

  • Chapter

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 192))

Abstract

Tobacco use through cigarette smoking is the leading preventable cause of death in the developed world. Nicotine, a psychoactive component of tobacco, appears to play a major role in tobacco dependence, but the reinforcing effects of nicotine have often been difficult to demonstrate directly in controlled studies with laboratory animals or human subjects. Here we update our earlier review published in Psychopharmacology (Berl) in 2006 on findings obtained with various procedures developed to study dependence-related behavioral effects of nicotine in experimental animals and humans. Results obtained with drug self-administration, conditioned place preference, subjective reports of nicotine effects and nicotine discrimination indicate that nicotine can function as an effective reinforcer of drug-seeking and drug-taking behavior both in experimental animals and humans under appropriate conditions. Interruption of chronic nicotine exposure produces ratings of drug withdrawal and withdrawal symptoms that may contribute to relapse. Difficulties encountered in demonstrating reinforcing effects of nicotine under some conditions, relative to other drugs of abuse, may be due to weaker primary reinforcing effects of nicotine, to aversive effects produced by nicotine, or to a more critical contribution of environmental stimuli to the maintenance of drug-seeking and drug-taking behavior with nicotine than with other drugs of abuse. Several recent reports suggest that other chemical substances inhaled along with nicotine in tobacco smoke may play a role in sustaining smoking behavior. However, conflicting results have been obtained with mice and rats and these findings have not yet been validated in nonhuman primates or human subjects. Taken together, these findings suggest that nicotine acts as a typical drug of abuse in experimental animals and humans in appropriate situations.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adriani W, Spijker S, Deroche-Gamonet V, Laviola G, Le Moal M, Smit AB, Piazza PV (2003) Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 23:4712–4716

    PubMed  CAS  Google Scholar 

  • Agatsuma S, Lee M, Zhu H, Chen K, Shih JC, Seif I, Hiroi N (2006) Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum Mol Genet 15:2721–2731

    PubMed  CAS  Google Scholar 

  • Ahmed SH, Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298–300

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Arlington, VA

    Google Scholar 

  • Ando K, Miyata H, Hironaka N, Tsuda T, Yanagita T (1993) The discriminative effects of nicotine and their central sites in rats. Yakubutsu Seishin Kodo 13:129–136

    PubMed  CAS  Google Scholar 

  • Andreoli M, Tessari M, Pilla M, Valerio E, Hagan JJ, Heidbreder CA (2003) Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 28:1272–1280

    PubMed  CAS  Google Scholar 

  • Anthenelli RM, Despres JP (2004) Effects of Rimonabant in the reduction of major cardiovascular risk factors. Results from the STRATUS-US trial (smoking cessation in smokers motivated to quit), American College of Cardiology 53rd Annual Scientific Session, New Orleans, LA

    Google Scholar 

  • Arroyo M, Markou A, Robbins TW, Everitt BJ (1999) Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous acces to cocaine. Psychopharmacology 140:331–344

    Google Scholar 

  • Ator NA, Griffiths RR (1983) Nicotine self-administration in baboons. Pharmacol Biochem Behav 19:993–1003

    PubMed  CAS  Google Scholar 

  • Balster RL (1992) Preclinical methods for the development of pharmacotherapies of cocaine abuse. In: Harris LS (ed) Problems of drug dependence. National Institute on Drug Abuse, Rockville, pp 160–164

    Google Scholar 

  • Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31–43

    PubMed  CAS  Google Scholar 

  • Belluzzi JD, Lee AG, Oliff HS, Leslie FM (2004a) Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology 174:389–395

    CAS  Google Scholar 

  • Belluzzi JD, Wang R, Leslie FM (2004b) Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology 30:705–712

    Google Scholar 

  • Berlin I, Anthenelli RM (2001) Monoamine oxidases and tobacco smoking. Int J Neuropsy-chopharmacol 4:33–42

    CAS  Google Scholar 

  • Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, Ho ML, Saxena S, Baxter LR Jr, Madsen D, Jarvik ME (2002) Brain metabolic changes during cigarette craving. Arch Gen Psychiatry 59:1162–1172

    Google Scholar 

  • Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED (2004) Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res 130:269–281

    PubMed  Google Scholar 

  • Brower VG, Fu Y, Matta SG, Sharp BM (2002) Rat strain differences in nicotine self-administration using an unlimited access paradigm. Brain Res 930:12–20

    PubMed  CAS  Google Scholar 

  • Bruijnzeel AW, Markou A (2003) Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50:20–28

    PubMed  CAS  Google Scholar 

  • Buczek Y, Le AD, Stewart J, Shaham Y (1999) Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology 144:183–188

    PubMed  CAS  Google Scholar 

  • Butschky MF, Bailey D, Henningfield JE, Pickworth WB (1995) Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav 50:91–96.

    PubMed  CAS  Google Scholar 

  • Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A, Perkins KA, Sved AF (2001) Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70:515–530

    PubMed  CAS  Google Scholar 

  • Caggiula AR, Donny EC, Chaudhri N, Perkins KA, Evans-Martin FF, Sved AF (2002) Importance of nonpharmacological factors in nicotine self-administration. Physiol Behav 77:683–687

    PubMed  CAS  Google Scholar 

  • Cahill K, Stead LF, Lancaster T (2007) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2007(1) CD006103. doi: 10.1002/14651858.CD006103.pub2

    Google Scholar 

  • Chance WT, Murfin D, Krynock GM, Rosecrans JA (1977) A description of the nicotine stimulus and tests of its generalization to amphetamine. Psychopharmacology 55:19–26

    PubMed  CAS  Google Scholar 

  • Chaudhri N, Caggiula AR, Donny EC, Palmatier MI, Liu X, Sved AF (2006a) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology 184:353–366

    CAS  Google Scholar 

  • Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib M, Craven L, Palmatier MI, Liu X, Sved AF (2006b) Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine. Psychopharmacology 189:27–36

    CAS  Google Scholar 

  • Chaudhri N, Caggiula AR, Donny EC, Booth S, Gharib M, Craven L, Palmatier MI, Liu X, Sved AF (2007) Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: impact of nicotine dose and reinforcement schedule. Psychopharmacology 190: 353–362

    PubMed  CAS  Google Scholar 

  • Chiamulera C, Borgo C, Falchetto S, Valerio E, Tessari M (1996) Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology 127:102–107

    PubMed  CAS  Google Scholar 

  • Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD 3rd, O'Neill BT (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48:3474–3477

    PubMed  CAS  Google Scholar 

  • Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451–463

    PubMed  CAS  Google Scholar 

  • Cohen C, Perrault G, Griebel G, Soubrie P (2005) Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB(1)) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology 30:145–155

    PubMed  CAS  Google Scholar 

  • Colpaert FC (1999) Drug discrimination in neurobiology. Pharmacol Biochem Behav 64:337–345

    PubMed  CAS  Google Scholar 

  • Corrigall WA, Coen KM (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99:473–478

    PubMed  CAS  Google Scholar 

  • Corrigall WA, Coen KM (1994) Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus. Pharmacol Biochem Behav 48:817–820

    PubMed  CAS  Google Scholar 

  • Cryan JF, Bruijnzeel AW, Skjei KL, Markou A (2003a) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology 168:347–358

    CAS  Google Scholar 

  • Cryan JF, Gasparini F, van Heeke G, Markou A (2003b) Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion. Drug Discov Today 8:1025–1034

    CAS  Google Scholar 

  • Dar R, Frenk H (2002) Nicotine self-administration in animals: a reevaluation. Addict Res Theory 10:545–579

    Google Scholar 

  • Dar R, Frenk H (2004) Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology 173:18–26

    PubMed  CAS  Google Scholar 

  • de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacol. 75:134–143

    Google Scholar 

  • Deneau GA, Inoki R (1967) Nicotine self-administration in monkeys. Ann N Y Acad Sci 142: 277–279

    Google Scholar 

  • DeNoble VJ, Mele PC (2005) Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology 184:266–272

    PubMed  Google Scholar 

  • Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014–1017

    PubMed  CAS  Google Scholar 

  • Desai RI, Barber DJ, Terry P (2003) Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology 167:335–343

    PubMed  CAS  Google Scholar 

  • Donny EC, Caggiula AR, Knopf S, Brown C (1995) Nicotine self-administration in rats. Psychopharmacology 122:390–394

    PubMed  CAS  Google Scholar 

  • Donny EC, Caggiula AR, Mielke MM, Jacobs KS, Rose C, Sved AF (1998) Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology 136:83–90

    PubMed  CAS  Google Scholar 

  • Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology 147:135–142

    PubMed  CAS  Google Scholar 

  • Donny EC, Chaudhri N, Caggiula AR, Evans-Martin FF, Booth S, Gharib MA, Clements LA, Sved AF (2003) Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology 169:68–76

    PubMed  CAS  Google Scholar 

  • Dravolina OA, Zakharova ES, Shekunova EV, Zvartau EE, Danysz W, Bespalov AY (2007) mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats. Neuropharmacology 52:263–269

    PubMed  CAS  Google Scholar 

  • Due DL, Huettel SA, Hall WG, Rubin DC (2002) Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 159:954–960

    PubMed  Google Scholar 

  • Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393:76–79

    PubMed  CAS  Google Scholar 

  • Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology 168:31–41

    PubMed  CAS  Google Scholar 

  • Erb S, Shaham Y, Stewart J (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 128:408–412

    PubMed  CAS  Google Scholar 

  • Ettenberg A, Geist TD (1991) Animal model for investigating the anxiogenic effects of selfadministered cocaine. Psychopharmacology 103:455–461

    PubMed  CAS  Google Scholar 

  • Everitt BJ, Robbins TW (2000) Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology 153:17–30

    PubMed  CAS  Google Scholar 

  • Fiore MC (2000) US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care 45:1200–1262.

    PubMed  CAS  Google Scholar 

  • Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER (2000) Treating tobacco use and dependence. Clinical practice guideline. Public Health Service, U.S. Department of Health and Human Service, Washington DC

    Google Scholar 

  • Forget B, Hamon M, Thiebot MH (2005) Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology 181:722–734

    PubMed  CAS  Google Scholar 

  • Forget B, Barthelemy S, Saurini F, Hamon M, Thiebot MH (2006) Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Psychopharmacology 189:59–69

    PubMed  CAS  Google Scholar 

  • Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996a) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733–736

    CAS  Google Scholar 

  • Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP (1996b) Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci USA 93:14065–14069

    CAS  Google Scholar 

  • Garrett BE, Griffiths RR (2001) Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers. J Pharmacol Exp Ther 296:486–494

    PubMed  CAS  Google Scholar 

  • Gasior M, Shoaib M, Yasar S, Jaszyna M, Goldberg SR (1999) Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine. J Pharmacol Exp Ther 288:1053–1073

    PubMed  CAS  Google Scholar 

  • George TP, O'Malley SS (2004) Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 25:42–48

    PubMed  CAS  Google Scholar 

  • Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J (1990) Smoking, smoking cessation, and major depression. JAMA 264:1546–1549

    PubMed  CAS  Google Scholar 

  • Glassman AH, Covey LS, Stetner F, Rivelli S (2001) Smoking cessation and the course of major depression: a follow-up study. Lancet 357:1929–1932

    PubMed  CAS  Google Scholar 

  • Goldberg SR (1975) Stimuli associated with drug injections as events that control behavior. Pharmacol Rev 27:325–340

    PubMed  CAS  Google Scholar 

  • Goldberg SR, Gardner ML (1981) Second-order schedules: extended sequences of behavior controlled by brief environmental stimuli associated with drug self-administration. NIDA Res Monogr 37:241–270

    PubMed  CAS  Google Scholar 

  • Goldberg SR, Henningfield JE (1988) Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol Biochem Behav 30:227–234

    PubMed  CAS  Google Scholar 

  • Goldberg SR, Spealman RD (1983) Suppression of behavior by intravenous injections of nicotine or by electric shocks in squirrel monkeys: effects of chlordiazepoxide and mecamylamine. J Pharmacol Exp Ther 224:334–340

    PubMed  CAS  Google Scholar 

  • Goldberg SR, Kelleher RT, Morse WH (1975) Second-order schedules of drug injection. Fed Proc 34:1771–1776

    PubMed  CAS  Google Scholar 

  • Goldberg SR, Spealman RD, Kelleher RT (1979) Enhancement of drug-seeking behavior by environmental stimuli associated with cocaine or morphine injections. Neuropharmacology 18:1015–1017

    PubMed  CAS  Google Scholar 

  • Goldberg SR, Kelleher RT, Goldberg DM (1981a) Fixed-ratio responding under second-order schedules of food presentation or cocaine injection. J Pharmacol Exp Ther 218:271–281

    CAS  Google Scholar 

  • Goldberg SR, Spealman RD, Goldberg DM (1981b) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science 214:573–575

    CAS  Google Scholar 

  • Goldberg SR, Spealman RD, Risner ME, Henningfield JE (1983) Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav 19:1011–1020

    PubMed  CAS  Google Scholar 

  • Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR (2006) Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA 296:47–55

    PubMed  CAS  Google Scholar 

  • Grabus SD, Martin BR, Brown SE, Damaj MI (2006) Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology 184:456–463

    PubMed  CAS  Google Scholar 

  • Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25:8593–8600

    PubMed  CAS  Google Scholar 

  • Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2006) Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci 24:3532–3540

    PubMed  Google Scholar 

  • Harvey DM, Yasar S, Heishman SJ, Panlilio LV, Henningfield JE, Goldberg SR (2004) Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology 175:134–142

    PubMed  CAS  Google Scholar 

  • Henningfield JE, Goldberg SR (1983a) Control of behavior by intravenous nicotine injections in human subjects. Pharmacol Biochem Behav 19:1021–1026

    CAS  Google Scholar 

  • Henningfield JE, Goldberg SR (1983b) Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 19:989–992

    CAS  Google Scholar 

  • Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1–12

    PubMed  CAS  Google Scholar 

  • Hill RT (1970) Facilitation of conditioned reinforcement as a mechanism of psychomotor stimulation. In: Garattimi ECAS (ed) Amphetamines and related compounds. Raven, New York, pp 781–795

    Google Scholar 

  • Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943–944

    PubMed  CAS  Google Scholar 

  • Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 58:322–328

    PubMed  CAS  Google Scholar 

  • Hughes JR (1989) Environmental determinants of the reinforcing effects of nicotine in humans. J Subst Abuse 1:319–329

    Google Scholar 

  • Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294

    PubMed  CAS  Google Scholar 

  • Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A (1984) Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology 83:82–87

    PubMed  CAS  Google Scholar 

  • Hughes JR, Hatsukami DK, Skoog KP (1986) Physical dependence on nicotine in gum. A placebo substitution trial. JAMA 255:3277–3279

    PubMed  CAS  Google Scholar 

  • Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW (1991) Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 48:52–59

    PubMed  CAS  Google Scholar 

  • Hughes JR, Higgins ST, Bickel WK (1994) Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89:1461–1470

    PubMed  CAS  Google Scholar 

  • Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195–1202

    PubMed  CAS  Google Scholar 

  • Huston-Lyons D, Kornetsky C (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacol Biochem Behav 41:755–759

    PubMed  CAS  Google Scholar 

  • Isola R, Vogelsberg V, Wemlinger TA, Neff NH, Hadjiconstantinou M (1999) Nicotine abstinence in the mouse. Brain Res 850:189–196

    PubMed  CAS  Google Scholar 

  • Jones HE, Garrett BE, Griffiths RR (1999) Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288:188–197

    PubMed  CAS  Google Scholar 

  • Jorenby D (2002) Clinical efficacy of bupropion in the management of smoking cessation. Drugs 62(Suppl 2):25–35

    PubMed  CAS  Google Scholar 

  • Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto ML, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685–691

    PubMed  CAS  Google Scholar 

  • Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296:56–63

    PubMed  CAS  Google Scholar 

  • Kalman D (2002) The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nicotine Tob Res 4:25–70

    PubMed  CAS  Google Scholar 

  • Katz JL, Goldberg SR (1988) Preclinical assessment of abuse liability of drugs. Agents Actions 23:18–26

    PubMed  CAS  Google Scholar 

  • Katz JL, Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology 168:21–30

    PubMed  CAS  Google Scholar 

  • Kenny PJ, Markou A (2001) Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav 70:531–549

    PubMed  CAS  Google Scholar 

  • Kumar R, Reavill C, Stolerman IP (1987) Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. Br J Pharmacol 90:239–246

    PubMed  CAS  Google Scholar 

  • Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL, Henningfield JE, Goldberg SR (1991) The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther 259:1165–1173

    PubMed  CAS  Google Scholar 

  • Laviolette SR, Van Der Kooy D (2003) Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry 8:50–59

    PubMed  CAS  Google Scholar 

  • Le Foll B, George TP (2007) Treatment of tobacco dependence: integrating recent progress into practice. CMAJ 177:1373–1380

    PubMed  Google Scholar 

  • Le Foll B, Goldberg SR (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15:2139–2143

    PubMed  Google Scholar 

  • Le Foll B, Goldberg SR (2005a) Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 312:875–883

    Google Scholar 

  • Le Foll B, Goldberg SR (2005b) Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans. Trends Pharmacol Sci 26:287–293

    Google Scholar 

  • Le Foll B, Goldberg SR (2005c) Ethanol does not affect discriminative-stimulus effects of nicotine in rats. Eur J Pharmacol 519:96–102

    Google Scholar 

  • Le Foll B, Goldberg SR (2005d) Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology 178:481–492

    Google Scholar 

  • Le Foll B, Goldberg SR (2006) Nicotine as a typical drug of abuse in experimental animals and humans. Psychopharmacology 184:367–381

    PubMed  CAS  Google Scholar 

  • Le Foll B, Schwartz J-C, Sokoloff P (2000) Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 15:140–146

    PubMed  Google Scholar 

  • Le Foll B, Schwartz J-C, Sokoloff P (2003a) Disruption of nicotine conditioning by dopamine D3 receptor ligands. Mol Psychiatry 8:225–230

    Google Scholar 

  • Le Foll B, Diaz J, Sokoloff P (2003b) Increased dopamine D3 receptor expression accompanying behavioural sensitization to nicotine in rats. Synapse 47:176–183

    Google Scholar 

  • Le Foll B, Goldberg SR, Sokoloff P (2005a) Dopamine Neuropharmacology 49:525–541

    Google Scholar 

  • Le Foll B, Melihan-Cheinin P, Rostoker G, Lagrue G for the working group of AFSSAPS (2005b) Smoking cessation guidelines: evidence-based recommendations of the French Health Products Safety Agency. Eur. Psychiatry 20:431–441

    Google Scholar 

  • Le Foll B, Sokoloff P, Stark H, Goldberg SR (2005c) Dopamine D3 ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30:720–730

    Google Scholar 

  • Le Foll B, Goldberg SR, Sokoloff P (2007a) Dopamine D3 receptor ligands for the treatment of tobacco dependence. Expert Opin Investig Drugs 16:45–57

    Google Scholar 

  • Le Foll B, Wertheim C, Goldberg SR (2007b) High reinforcing efficacy of nicotine in non-human primates. PLoS One 2:e230

    Google Scholar 

  • LeSage MG, Keyler DE, Shoeman D, Raphael D, Collins G, Pentel PR (2002) Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacol Biochem Behav 72:279–289

    PubMed  CAS  Google Scholar 

  • LeSage MG, Keyler DE, Collins G, Pentel PR (2003) Effects of continuous nicotine infusion on nicotine self-administration in rats: relationship between continuously infused and selfadministered nicotine doses and serum concentrations. Psychopharmacology 170:278–286

    PubMed  CAS  Google Scholar 

  • Lesage MG, Burroughs D, Dufek M, Keyler DE, Pentel PR (2004) Reinstatement of nicotine selfadministration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacol Biochem Behav 79:507–513

    PubMed  CAS  Google Scholar 

  • Liechti ME, Lhuillier L, Kaupmann K, Markou A (2007) Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J Neurosci 27:9077–9085

    PubMed  CAS  Google Scholar 

  • Lindblom N, de Villiers SH, Kalayanov G, Gordon S, Johansson AM, Svensson TH (2002) Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration 69:254–260

    PubMed  CAS  Google Scholar 

  • Liu X, Caggiula AR, Yee SK, Nobuta H, Poland RE, Pechnick RN (2006) Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats. Psychopharma-cology 184:417–425

    CAS  Google Scholar 

  • Liu X, Caggiula AR, Yee SK, Nobuta H, Sved AF, Pechnick RN, Poland RE (2007) Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats. Neuropsychopharmacology 32:710–718

    PubMed  CAS  Google Scholar 

  • Malin DH, Lake JR, Newlin-Maultsby P, Roberts LK, Lanier JG, Carter VA, Cunningham JS, Wilson OB (1992) Rodent model of nicotine abstinence syndrome. Pharmacol Biochem Behav 43:779–784

    PubMed  CAS  Google Scholar 

  • Manzardo AM, Stein L, Belluzzi JD (2002) Rats prefer cocaine over nicotine in a two-lever selfadministration choice test. Brain Res 924:10–19

    PubMed  CAS  Google Scholar 

  • Markou A, Weiss F, Gold LH, Caine B, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112:163–182

    PubMed  CAS  Google Scholar 

  • Martellotta MC, Kuzmin A, Zvartau E, Cossu G, Gessa GL, Fratta W (1995) Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 52:271–274

    PubMed  CAS  Google Scholar 

  • Meil WM, See RE (1996) Conditioned cue recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse. Behav Pharmacol 7: 754–763

    PubMed  CAS  Google Scholar 

  • Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63: 1209–1216

    PubMed  CAS  Google Scholar 

  • Miyata H, Ando K, Yanagita T (1999) Medial prefrontal cortex is involved in the discriminative stimulus effects of nicotine in rats. Psychopharmacology 145:234–236

    PubMed  CAS  Google Scholar 

  • Miyata H, Ando K, Yanagita T (2002) Brain regions mediating the discriminative stimulus effects of nicotine in rats. Ann N Y Acad Sci 965:354–363

    PubMed  CAS  Google Scholar 

  • Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR (2006) Smoking cessation with varenicline, a selective {alpha}4beta2 nicotinic receptor partial agonist: results From a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med 166:1561–1568

    PubMed  Google Scholar 

  • O'Brien CP (2003) Research advances in the understanding and treatment of addiction. Am J Addict 12(Suppl 2):S36–47

    PubMed  Google Scholar 

  • O'Dell LE, Koob GF (2007) ‘Nicotine deprivation effect’ in rats with intermittent 23-hour access to intravenous nicotine self-administration. Pharmacol Biochem Behav 86:346–353

    PubMed  Google Scholar 

  • O'Dell LE, Chen SA, Smith RT, Specio SE, Balster RL, Paterson NE, Markou A, Zorrilla EP, Koob GF (2007) Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats. J Pharmacol Exp Ther 320:180–193

    PubMed  Google Scholar 

  • Olausson P, Jentsch JD, Taylor JR (2003) Repeated nicotine exposure enhances reward-related learning in the rat. Neuropsychopharmacology 28:1264–1271

    PubMed  CAS  Google Scholar 

  • Olausson P, Jentsch JD, Taylor JR (2004) Nicotine enhances responding with conditioned reinforcement. Psychopharmacology 171:173–178

    PubMed  CAS  Google Scholar 

  • Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K (2006) Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med 166:1571–1577

    PubMed  CAS  Google Scholar 

  • Overstreet DH (1995) Differential effects of nicotine in inbred and selectively bred rodents. Behav Genet 25:179–185

    PubMed  CAS  Google Scholar 

  • Overstreet DH, Pucilowski O, Rezvani AH, Janowsky DS (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology 121:27–37

    PubMed  CAS  Google Scholar 

  • Pak AC, Ashby CR, Heidbreder CA, Pilla M, Gilbert J, Xi ZX, Gardner EL (2006) The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 9:585–602

    PubMed  CAS  Google Scholar 

  • Palmatier MI, Liu X, Caggiula AR, Donny EC, Sved AF (2007a) The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine. Neuropsychopharmacology 32:1098–1108

    CAS  Google Scholar 

  • Palmatier MI, Matteson GL, Black JJ, Liu X, Caggiula AR, Craven L, Donny EC, Sved AF (2007b) The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections. Drug Alcohol Depend 89:52–59

    CAS  Google Scholar 

  • Panlilio LV, Yasar S, Nemeth-Coslett R, Katz JL, Henningfield JE, Solinas M, Heishman SJ, Schindler CW, Goldberg SR (2005) Human cocaine-seeking behavior and its control by drugassociated stimuli in the laboratory. Neuropsychopharmacology 30:433–443

    PubMed  CAS  Google Scholar 

  • Paterson NE, Markou A (2003) Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14:2229–2232

    PubMed  CAS  Google Scholar 

  • Paterson NE, Markou A (2004) Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats. Psychopharmacology 173:64–72

    PubMed  CAS  Google Scholar 

  • Paterson NE, Semenova S, Gasparini F, Markou A (2003) The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167:257–264

    PubMed  CAS  Google Scholar 

  • Paterson NE, Froestl W, Markou A (2004) The GABA(B) receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172: 179–186

    PubMed  CAS  Google Scholar 

  • Perkins KA (2004) Response to Dar and Frenk (2004), Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology 175:256–258; author reply 259–61

    PubMed  CAS  Google Scholar 

  • Perkins KA, Grobe JE, Weiss D, Fonte C, Caggiula A (1996) Nicotine preference in smokers as a function of smoking abstinence. Pharmacol Biochem Behav 55:257–263

    PubMed  CAS  Google Scholar 

  • Perkins KA, Sanders M, D'Amico D, Wilson A (1997) Nicotine discrimination and selfadministration in humans as a function of smoking status. Psychopharmacology 131:361–370

    PubMed  CAS  Google Scholar 

  • Perkins KA, Sanders M, Fonte C, Wilson AS, White W, Stiller R, McNamara D (1999) Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharmacology 142:158–164

    PubMed  CAS  Google Scholar 

  • Perkins KA, Fonte C, Meeker J, White W, Wilson A (2001) The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pretreatment. Behav Pharmacol 12: 35–44

    PubMed  CAS  Google Scholar 

  • Perkins KA, Fonte C, Blakesley-Ball R, Stolinski A, Wilson AS (2005) The influence of alcohol pre-treatment on the discriminative stimulus, subjective, and relative reinforcing effects of nicotine. Behav Pharmacol 16:521–529

    PubMed  CAS  Google Scholar 

  • Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, Fuxe K, Changeux JP (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173–177.

    PubMed  CAS  Google Scholar 

  • Picciotto MR, Brunzell DH, Caldarone BJ (2002) Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13:1097–1106

    PubMed  CAS  Google Scholar 

  • Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psy-chopharmacology 91:391–393

    CAS  Google Scholar 

  • Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C (1983) Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology 81:54–60

    PubMed  CAS  Google Scholar 

  • Rasmussen T, Swedberg MD (1998) Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice. Pharmacol Biochem Behav 60:567–573

    PubMed  CAS  Google Scholar 

  • Rauhut AS, Neugebauer N, Dwoskin LP, Bardo MT (2003) Effect of bupropion on nicotine self-administration in rats. Psychopharmacology 169:1–9

    PubMed  CAS  Google Scholar 

  • Reavill C, Stolerman IP, Kumar R, Garcha HS (1986) Chlorisondamine blocks acquisition of the conditioned taste aversion produced by (-)-nicotine. Neuropharmacology 25:1067–1069

    PubMed  CAS  Google Scholar 

  • Risner ME, Goldberg SR (1983) A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J Pharmacol Exp Ther 224:319–326

    PubMed  CAS  Google Scholar 

  • Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247–291

    PubMed  CAS  Google Scholar 

  • Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103–114

    PubMed  CAS  Google Scholar 

  • Robinson JH, Pritchard WS (1992) The role of nicotine in tobacco use. Psychopharmacology 108:397–407

    PubMed  CAS  Google Scholar 

  • Robinson ML, Houtsmuller EJ, Moolchan ET, Pickworth WB (2000) Placebo cigarettes in smoking research. Exp Clin Psychopharmacol 8:326–332

    PubMed  CAS  Google Scholar 

  • Robinson SE, James JR, Lapp LN, Vann RE, Gross DF, Philibin SD, Rosecrans JA (2006) Evidence of cellular nicotinic receptor desensitization in rats exhibiting nicotine-induced acute tolerance. Psychopharmacology 184:306–313

    PubMed  CAS  Google Scholar 

  • Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE (2007) Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985–994

    PubMed  CAS  Google Scholar 

  • Rose JE, Sampson A, Levin ED, Henningfield JE (1989) Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933–938

    PubMed  CAS  Google Scholar 

  • Rose JE, Corrigall WA (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology 130:28–40

    PubMed  CAS  Google Scholar 

  • Rose JE, Behm FM, Westman EC, Johnson M (2000) Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol Biochem Behav 67:71–81

    PubMed  CAS  Google Scholar 

  • Rose JE, Behm FM, Westman EC (2001) Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking. Pharmacol Biochem Behav 68:187–197

    PubMed  CAS  Google Scholar 

  • Rose JE, Behm FM, Westman EC, Bates JE (2003a) Mecamylamine acutely increases human intravenous nicotine self-administration. Pharmacol Biochem Behav 76:307–313

    CAS  Google Scholar 

  • Rose JE, Behm FM, Westman EC, Bates JE, Salley A (2003b) Pharmacologic and sensorimotor components of satiation in cigarette smoking. Pharmacol Biochem Behav 76:243–250

    CAS  Google Scholar 

  • Rosecrans JA (1979) Nicotine as a discriminative stimulus to behavior: its characterization and relevance to smoking behavior. NIDA Res Monogr 23:58–69

    PubMed  Google Scholar 

  • Rosecrans JA, Meltzer LT (1981) Central sites and mechanisms of action of nicotine. Neurosci Biobehav Rev 5:497–501

    PubMed  CAS  Google Scholar 

  • Salin-Pascual RJ, Drucker-Colin R (1998) A novel effect of nicotine on mood and sleep in major depression. Neuroreport 9:57–60

    PubMed  CAS  Google Scholar 

  • Salin-Pascual RJ, Rosas M, Jimenez-Genchi A, Rivera-Meza BL, Delgado-Parra V (1996) Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 57:387–389

    PubMed  CAS  Google Scholar 

  • Sannerud CA, Prada J, Goldberg DM, Goldberg SR (1994) The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys. Eur J Pharmacol 271:461–469

    PubMed  CAS  Google Scholar 

  • Schindler CW, Panlilio LV, Goldberg SR (2002) Second-order schedules of drug selfadministration in animals. Psychopharmacology 163:327–344.

    PubMed  CAS  Google Scholar 

  • Schuster CR, Woods JH (1968) The conditioned reinforcing effects of stimuli associated with morphine reinforcement. Int J Addict 3:223–230

    Google Scholar 

  • Self DW, Nestler EJ (1988) Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Dep. 51:49–60

    Google Scholar 

  • Shaham Y, Rajabi H, Stewart J (1996) Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J Neurosci 16:1957–1963

    PubMed  CAS  Google Scholar 

  • Shaham Y, Adamson LK, Grocki S, Corrigall WA (1997) Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology 130:396–403

    PubMed  CAS  Google Scholar 

  • Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003) The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 168:3–20

    PubMed  CAS  Google Scholar 

  • Shalev U, Grimm JW, Shaham Y (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54:1–42

    PubMed  CAS  Google Scholar 

  • Shiffman S, Shumaker SA, Abrams DB, Cohen S, Garvey A, Grunberg NE, Swan GE (1986) Models of smoking relapse. Health Psychol 5(Suppl):13–27

    PubMed  Google Scholar 

  • Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000a) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 148:33–40

    CAS  Google Scholar 

  • Shiffman S, Khayrallah M, Nowak R (2000b) Efficacy of the nicotine patch for relief of craving and withdrawal 7–10 weeks after cessation. Nicotine Tob Res 2:371–378

    CAS  Google Scholar 

  • Shiffman S, Shadel WG, Niaura R, Khayrallah MA, Jorenby DE, Ryan CF, Ferguson CL (2003) Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology 166:343–350

    PubMed  CAS  Google Scholar 

  • Shoaib M, Stolerman IP (1995) Conditioned taste aversions in rats after intracerebral administration of nicotine. Behav Pharmacol 6:375–385

    PubMed  CAS  Google Scholar 

  • Shoaib M, Stolerman IP, Kumar RC (1994) Nicotine-induced place preferences following prior nicotine exposure in rats. Psychopharmacology 113:445–452

    PubMed  CAS  Google Scholar 

  • Shoaib M, Schindler CW, Goldberg SR (1997) Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology 129:35–43

    PubMed  CAS  Google Scholar 

  • Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530–539

    PubMed  CAS  Google Scholar 

  • Shoaib M, Sidhpura N, Shafait S (2003) Investigating the actions of bupropion on dependencerelated effects of nicotine in rats. Psychopharmacology 165:405–412

    PubMed  CAS  Google Scholar 

  • Silagy C, Mant D, Fowler G, Lancaster T (2000) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2000(3):CD000146

    Google Scholar 

  • Slifer BL, Balster RL (1985) Intravenous self-administration of nicotine: with and without schedule-induction. Pharmacol Biochem Behav 22:61–69

    PubMed  CAS  Google Scholar 

  • Sofuoglu M, Yoo S, Hill KP, Mooney M (2007) Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacology 33:715–720

    PubMed  Google Scholar 

  • Solinas M, Panlilio LV, Justinova Z, Yasar S, Goldberg SR (2006) Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats. Nat Protoc 1:1194–1206

    PubMed  CAS  Google Scholar 

  • Soria R, Stapleton JM, Gilson SF, Sampson-Cone A, Henningfield JE, London ED (1996) Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psy-chopharmacology 128:221–226

    CAS  Google Scholar 

  • Spealman RD (1983) Maintenance of behavior by postponement of scheduled injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 227:154–159

    PubMed  CAS  Google Scholar 

  • Spealman RD, Goldberg SR (1978) Drug self-administration by laboratory animals: Control by schedules of reinforcement. Annu Rev Pharmacol Toxicol 18:313–339

    PubMed  CAS  Google Scholar 

  • Spealman RD, Goldberg SR (1982) Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther 223:402–408

    PubMed  CAS  Google Scholar 

  • Spealman RD, Goldberg SR, Gardner ML (1981) Behavioral effects of nicotine: schedule-controlled responding by squirrel monkeys. J Pharmacol Exp Ther 216:484–491

    PubMed  CAS  Google Scholar 

  • Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV (1999) Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64:327–336

    PubMed  CAS  Google Scholar 

  • Stewart J (1983) Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug-administration. Prog Neuropsychopharmacol Biol Psychiatry 7:591–597

    PubMed  CAS  Google Scholar 

  • Stolerman IP (1988) Characterization of central nicotinic receptors by studies on the nicotine cue and conditioned taste aversion in rats. Pharmacol Biochem Behav 30:235–242

    PubMed  CAS  Google Scholar 

  • Stolerman IP (1989) Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology 97:131–138

    PubMed  CAS  Google Scholar 

  • Stolerman IP (1999) Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behav Pharmacol 10:559–580

    PubMed  CAS  Google Scholar 

  • Stolerman IP, Shoaib M (1991) The neurobiology of tobacco addiction. Trends Pharmacol Sci 12:467–473

    PubMed  CAS  Google Scholar 

  • Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413–419

    PubMed  CAS  Google Scholar 

  • Stolerman IP, Naylor C, Elmer GI, Goldberg SR (1999) Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology 141:297–306

    PubMed  CAS  Google Scholar 

  • Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-beta-erythroidine in rats. Psychopharmacology 129:390–397

    PubMed  CAS  Google Scholar 

  • Suzuki T, Ise Y, Tsuda M, Maeda J, Misawa M (1996) Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur J Pharmacol 314:281–284

    PubMed  CAS  Google Scholar 

  • Takada K, Hagen TJ, Cook JM, Goldberg SR, Katz JL (1988) Discriminative stimulus effects of intravenous nicotine in squirrel monkeys. Pharmacol Biochem Behav 30:243–247

    PubMed  CAS  Google Scholar 

  • Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, Whiteaker P, Marks MJ, Collins AC, Lester HA (2004) Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization. Science 306:1029–1032

    PubMed  CAS  Google Scholar 

  • Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 357:1571–1575

    PubMed  CAS  Google Scholar 

  • Thorsteinsson HS, Gillin JC, Patten CA, Golshan S, Sutton LD, Drummond S, Clark CP, Kelsoe J, Rapaport M (2001) The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology 24: 350–358

    PubMed  CAS  Google Scholar 

  • Tiffany ST, Cox LS, Elash CA (2000) Effects of transdermal nicotine patches on abstinenceinduced and cue-elicited craving in cigarette smokers. J Consult Clin Psychol 68:233–240

    PubMed  CAS  Google Scholar 

  • Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E Jr, Janowsky DS, Kling MA (1999) Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 142:193– 199

    PubMed  CAS  Google Scholar 

  • Tizabi Y, Rezvani AH, Russell LT, Tyler KY, Overstreet DH (2000) Depressive characteristics of FSL rats: involvement of central nicotinic receptors. Pharmacol Biochem Behav 66:73–77

    PubMed  CAS  Google Scholar 

  • Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR (2006) Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA 296:64–71

    PubMed  CAS  Google Scholar 

  • Valentine JD, Hokanson JS, Matta SG, Sharp BM (1997) Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology 133:300–304

    PubMed  CAS  Google Scholar 

  • Vanderschuren LJ, Everitt BJ (2004) Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305:1017–1019

    PubMed  CAS  Google Scholar 

  • Vastola BJ, Douglas LA, Varlinskaya EI, Spear LP (2002) Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 77:107–114

    PubMed  CAS  Google Scholar 

  • Villegier AS, Blanc G, Glowinski J, Tassin JP (2003) Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol Biochem Behav 76: 267–274

    PubMed  CAS  Google Scholar 

  • Villegier AS, Salomon L, Granon S, Changeux JP, Belluzzi JD, Leslie FM, Tassin JP (2006) Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology 31:1704–1713

    PubMed  CAS  Google Scholar 

  • Wakasa Y, Takada K, Yanagita T (1995) Reinforcing effect as a function of infusion speed in intravenous self-administration of nicotine in rhesus monkeys. Nihon Shinkei Seishin Yakurigaku Zasshi 15:53–59

    PubMed  CAS  Google Scholar 

  • Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH (2004) Cue-provoked craving and nicotine replacement therapy in smoking cessation. J Consult Clin Psychol 72:1136–1143

    PubMed  Google Scholar 

  • Watkins SS, Koob GF, Markou A (2000) Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2:19–37

    PubMed  CAS  Google Scholar 

  • West RJ, Russell MA (1985) Effects of withdrawal from long-term nicotine gum use. Psychol Med 15:891–893

    PubMed  CAS  Google Scholar 

  • West RJ, Jarvis MJ, Russell MA, Carruthers ME, Feyerabend C (1984a) Effect of nicotine replacement on the cigarette withdrawal syndrome. Br J Addict 79:215–219

    CAS  Google Scholar 

  • West RJ, Russell MA, Jarvis MJ, Feyerabend C (1984b) Does switching to an ultra-low nicotine cigarette induce nicotine withdrawal effects? Psychopharmacology 84:120–123

    CAS  Google Scholar 

  • Wiley JL, Lavecchia KL, Martin BR, Damaj MI (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol 10:129–135

    PubMed  CAS  Google Scholar 

  • Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113–118

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Translational Addiction Research Laboratory, CAMH, Departments of Psychiatry, Pharmacology and Family and Community Medicine, University of Toronto, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, ON, M5S 2S1, Canada

    Bernard Le Foll

  2. Preclinical Pharmacology Section, Intramural Research Program, NIDA, NIH, DHHS, 5500 Nathan Shock Drive, Baltimore, MD, 21224, USA

    Steven R. Goldberg

Authors
  1. Bernard Le Foll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven R. Goldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pinney Associates, 3 Bethesda Metro Center, Bethesda, MD, 20814-3472, USA

    Jack E. Henningfield

  2. UCLA Semel Institute for Neuroscience and Human Behavior, 760 Westwood Plaza, Los Angeles, CA, 90024-1759, USA

    Edythe D. London

  3. Center for Brain Research, Bornova, Ege University, Izmir, 35100, Turkey

    Sakire Pogun

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Foll, B.L., Goldberg, S.R. (2009). Effects of Nicotine in Experimental Animals and Humans: An Update on Addictive Properties. In: Henningfield, J.E., London, E.D., Pogun, S. (eds) Nicotine Psychopharmacology. Handbook of Experimental Pharmacology, vol 192. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69248-5_12

Download citation

Publish with us

Policies and ethics

Search

Navigation